Clinical Trials Directory

Trials / Completed

CompletedNCT02051192

Brief Behavioral Treatment for Anxiety in Young Children

A Brief Behavioral Treatment for Anxiety in Young Children

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
58 (actual)
Sponsor
University of South Florida · Academic / Other
Sex
All
Age
3 Years – 7 Years
Healthy volunteers
Not accepted

Summary

Behaviorally and cognitive-behaviorally based therapeutic techniques (BT; CBT) that incorporate exposure therapy useful for treatment of anxiety disorders among typically developing children. Although a large amount of data demonstrate the effectiveness of of BT and CBT approaches for treating anxious youth, there is a gap in the literature for the effectiveness of these approaches for children under the age of seven. Evidence increasingly suggests that family factors such as accommodation and parenting style contribute significantly to the presence of anxiety symptoms as well as treatment outcomes, particularly in young children. These findings stress the importance of using a treatment approach in which parents are directly involved in education, parent training, and generalization of treatment effects. Therefore, this study aims to evaluate a new treatment program, parent-led behavioral treatment, for children ages 3 to 7 years of age who have a principal anxiety disorder diagnosis.

Conditions

Interventions

TypeNameDescription
BEHAVIORALParent-Led Exposure TherapyTherapists will work with families for 10 sessions, twice weekly. The first treatment session will be a 90 minute parent only psychoeducation and treatment preparation session. Each subsequent session will last up to 60 minutes and will consist of exposure therapy using developmentally appropriate modulated behavioral approaches such as Participant modeling (PM) and Reinforced practice (RP).
OTHERTreatment As UsualPatients randomized to the TAU arm will be instructed to continue receiving their prior interventions as recommended by their providers (e.g., psychotherapy, social skills training, behavioral interventions, family participation in family therapy or a parenting class, or pharmacological interventions). Treatment changes (e.g., medication increase, starting psychotherapy in the community) are not prohibited and will be monitored. Thus, treatment will continue as it would in standard practice. These participants may also elect to receive no treatment at all during the TAU period.

Timeline

Start date
2014-01-01
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2014-01-31
Last updated
2016-10-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02051192. Inclusion in this directory is not an endorsement.